Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. |
|---|---|
| Authors: | Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, U.K. melanie.davies@uhl-tr.nhs.uk., Bain SC; Institute of Life Science, Swansea University, Swansea, U.K., Atkin SL; Qatar Foundation, Weill Cornell Medical College, Doha, Qatar., Rossing P; Steno Diabetes Center, Gentofte, Denmark., Scott D; Clinical Research Development Associates, Rosedale, NY., Shamkhalova MS; Department of Diabetic Nephropathy, Endocrinology Research Centre, Moscow, Russia., Bosch-Traberg H; Novo Nordisk A/S, Søborg, Denmark., Syrén A; Novo Nordisk A/S, Søborg, Denmark., Umpierrez GE; Division of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, GA. |
| Source: | Diabetes care [Diabetes Care] 2016 Feb; Vol. 39 (2), pp. 222-30. Date of Electronic Publication: 2015 Dec 17. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26681713 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Davies+MJ%22">Davies MJ</searchLink>; Diabetes Research Centre, University of Leicester, Leicester, U.K. melanie.davies@uhl-tr.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Bain+SC%22">Bain SC</searchLink>; Institute of Life Science, Swansea University, Swansea, U.K.<br /><searchLink fieldCode="AU" term="%22Atkin+SL%22">Atkin SL</searchLink>; Qatar Foundation, Weill Cornell Medical College, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center, Gentofte, Denmark.<br /><searchLink fieldCode="AU" term="%22Scott+D%22">Scott D</searchLink>; Clinical Research Development Associates, Rosedale, NY.<br /><searchLink fieldCode="AU" term="%22Shamkhalova+MS%22">Shamkhalova MS</searchLink>; Department of Diabetic Nephropathy, Endocrinology Research Centre, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Bosch-Traberg+H%22">Bosch-Traberg H</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Syrén+A%22">Syrén A</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Umpierrez+GE%22">Umpierrez GE</searchLink>; Division of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, GA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2016 Feb; Vol. 39 (2), pp. 222-30. <i>Date of Electronic Publication: </i>2015 Dec 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26681713 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/dc14-2883 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 222 Titles: – TitleFull: Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davies MJ – PersonEntity: Name: NameFull: Bain SC – PersonEntity: Name: NameFull: Atkin SL – PersonEntity: Name: NameFull: Rossing P – PersonEntity: Name: NameFull: Scott D – PersonEntity: Name: NameFull: Shamkhalova MS – PersonEntity: Name: NameFull: Bosch-Traberg H – PersonEntity: Name: NameFull: Syrén A – PersonEntity: Name: NameFull: Umpierrez GE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2016 Feb Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1935-5548 Numbering: – Type: volume Value: 39 – Type: issue Value: 2 Titles: – TitleFull: Diabetes care Type: main |
| ResultId | 1 |
